NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers ...

Weeks into his new role as president and CEO of Bryn Mawr, Pa.-based Main Line Health, Edward Jimenez told Becker’s the five-hospital system — with more than 13,000 employees — is taking steps to stay ...

Former CDC officials warn that proposed fiscal 2026 budget cuts would slash funding by 54%, threatening critical health ...

We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...

The cost cutting announced last year will have a long term impact on internal R&D, coupled with the well documented high profile failures in external M&A/R&D. This is not just a patent cliff story.

Former FDA commissioner: ‘Cost-cutting’ may undo one of Trump’s best drug pricing achievements The generic drug policy office brought lower drug costs to Americans Adobe By Scott Gottlieb ...

“Cuts of $625 billion will force states to make tough choices: maintain current spending on Medicaid by raising taxes or reducing spending on other programs; or cut Medicaid spending by covering ...

Last month, the company announced it sought to cut an additional $1.2 billion — bringing its multiyear cost-savings target to $7.7 billion. Pfizer ended last year with 81,000 employees worldwide ...

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it ...

Back in May 2024, management added another $1.5 billion in planned savings to the existing $4 billion cost-cutting program. Guess what, by the end of 2024, the company had already hit $4 billion ...

Pfizer still expects that changes to the Medicare program resulting from the Inflation Reduction Act will hurt sales by $1 billion, dampening growth by approximately 1.6% compared with 2024.